Comparison of the safety and efficacy of loteprednol 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis

By White Eric M.   Macy Jonathan I.   Bateman Kirk M.   Comstock Timothy L.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 287-296

Informa Healthcare

Access to resources Recommend Favorite

A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%%/tobramycin 0.3%% with dexamethasone 0.1%%/tobramycin 0.3%% in the treatment of Chinese patients with blepharokeratoconjunctivitis

By Chen Minjie   Gong Lan   Sun Xinghuai   Gu Yangshun   He Xiangge   Qu Jia   Wang Lili   Zhang Mingzhi   Zhong Xingwu  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 385-394

Informa Healthcare

Access to resources Recommend Favorite

Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia

By Combes Alain   Luyt Charles-Edouard   Fagon Jean-Yves   Wolff Michel   Trouillet Jean-Louis   Chastre Jean  

Intensive Care Medicine, Vol. 32, Iss. 12, 2006-12 ,pp. : 1970-1978

Springer Publishing Company

Access to resources Recommend Favorite

Impact of antifungal treatment on Candida–Pseudomonas interaction: a preliminary retrospective case–control study

By Nseir Saad   Jozefowicz Elsa   Cavestri Béatrice   Sendid Boualem   Pompeo Christophe   Dewavrin Florent   Favory Raphaël   Roussel-Delvallez Micheline   Durocher Alain  

Intensive Care Medicine, Vol. 33, Iss. 1, 2007-01 ,pp. : 137-142

Springer Publishing Company

Access to resources Recommend Favorite

Lung deposition of continuous and intermittent intravenous ceftazidime in experimental Pseudomonas aeruginosa bronchopneumonia

By Girardi Cassio   Tonnellier Marc   Goldstein Ivan   Sartorius Alfonso   Wallet Frederic   Rouby Jean-Jacques  

Intensive Care Medicine, Vol. 32, Iss. 12, 2006-12 ,pp. : 2042-2048

Springer Publishing Company

Access to resources Recommend Favorite